300 related articles for article (PubMed ID: 36839790)
1. Biopolymers in Mucoadhesive Eye Drops for Treatment of Dry Eye and Allergic Conditions: Application and Perspectives.
Račić A; Krajišnik D
Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839790
[TBL] [Abstract][Full Text] [Related]
2. Alleviation of dry eye syndrome with one dose of antioxidant, anti-inflammatory, and mucoadhesive lysine-carbonized nanogels.
Lin PH; Jian HJ; Li YJ; Huang YF; Anand A; Huang CC; Lin HJ; Lai JY
Acta Biomater; 2022 Mar; 141():140-150. PubMed ID: 35081433
[TBL] [Abstract][Full Text] [Related]
3. Phenylboronic acid-tethered chondroitin sulfate-based mucoadhesive nanostructured lipid carriers for the treatment of dry eye syndrome.
Tan G; Li J; Song Y; Yu Y; Liu D; Pan W
Acta Biomater; 2019 Nov; 99():350-362. PubMed ID: 31449929
[TBL] [Abstract][Full Text] [Related]
4. A review on topical ophthalmic drug delivery system: Reference to viscosity enhancer.
Pawar PK; Rathod RD; Jagadale SR
Polim Med; 2024; 54(1):71-84. PubMed ID: 38533624
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in ocular drug delivery.
Achouri D; Alhanout K; Piccerelle P; Andrieu V
Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
[TBL] [Abstract][Full Text] [Related]
6. Effect of hydroxypropyl-β-cyclodextrin on the ocular bioavailability of dexamethasone from a pH-induced mucoadhesive hydrogel.
Kesavan K; Kant S; Singh PN; Pandit JK
Curr Eye Res; 2011 Oct; 36(10):918-29. PubMed ID: 21950697
[TBL] [Abstract][Full Text] [Related]
7. Ocular drug metabolism of the bioactivating antioxidant N-acetylcarnosine for vision in ophthalmic prodrug and codrug design and delivery.
Babizhayev MA
Drug Dev Ind Pharm; 2008 Oct; 34(10):1071-89. PubMed ID: 18777243
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses.
Gause S; Hsu KH; Shafor C; Dixon P; Powell KC; Chauhan A
Adv Colloid Interface Sci; 2016 Jul; 233():139-154. PubMed ID: 26318359
[TBL] [Abstract][Full Text] [Related]
9. Novel in situ gelling ophthalmic drug delivery system based on gellan gum and hydroxyethylcellulose: Innovative rheological characterization, in vitro and in vivo evidence of a sustained precorneal retention time.
Destruel PL; Zeng N; Seguin J; Douat S; Rosa F; Brignole-Baudouin F; Dufaÿ S; Dufaÿ-Wojcicki A; Maury M; Mignet N; Boudy V
Int J Pharm; 2020 Jan; 574():118734. PubMed ID: 31705970
[TBL] [Abstract][Full Text] [Related]
10. Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery.
Kaur IP; Smitha R
Drug Dev Ind Pharm; 2002 Apr; 28(4):353-69. PubMed ID: 12056529
[TBL] [Abstract][Full Text] [Related]
11. Review of Approaches for Increasing Ophthalmic Bioavailability for Eye Drop Formulations.
Lanier OL; Manfre MG; Bailey C; Liu Z; Sparks Z; Kulkarni S; Chauhan A
AAPS PharmSciTech; 2021 Mar; 22(3):107. PubMed ID: 33719019
[TBL] [Abstract][Full Text] [Related]
12. Insight into the Lubrication and Adhesion Properties of Hyaluronan for Ocular Drug Delivery.
Černohlávek M; Brandejsová M; Štěpán P; Vagnerová H; Hermannová M; Kopecká K; Kulhánek J; Nečas D; Vrbka M; Velebný V; Huerta-Angeles G
Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680064
[TBL] [Abstract][Full Text] [Related]
13. In-situ tear fluid dissolving nanofibers enable prolonged viscosity-enhanced dual drug delivery to the eye.
Rohde F; Walther M; Wächter J; Knetzger N; Lotz C; Windbergs M
Int J Pharm; 2022 Mar; 616():121513. PubMed ID: 35085733
[TBL] [Abstract][Full Text] [Related]
14. Tacrolimus Loaded Cationic Liposomes for Dry Eye Treatment.
Chen X; Wu J; Lin X; Wu X; Yu X; Wang B; Xu W
Front Pharmacol; 2022; 13():838168. PubMed ID: 35185587
[TBL] [Abstract][Full Text] [Related]
15. Bioactivation antioxidant and transglycating properties of N-acetylcarnosine autoinduction prodrug of a dipeptide L-carnosine in mucoadhesive drug delivery eye-drop formulation: powerful eye health application technique and therapeutic platform.
Babizhayev MA
Drug Test Anal; 2012 Jun; 4(6):468-85. PubMed ID: 21416634
[TBL] [Abstract][Full Text] [Related]
16. Design and Optimization of In Situ Gelling Mucoadhesive Eye Drops Containing Dexamethasone.
Szalai B; Jójárt-Laczkovich O; Kovács A; Berkó S; Balogh GT; Katona G; Budai-Szűcs M
Gels; 2022 Sep; 8(9):. PubMed ID: 36135271
[TBL] [Abstract][Full Text] [Related]
17. Optimization of hyaluronan-based eye drop formulations.
Salzillo R; Schiraldi C; Corsuto L; D'Agostino A; Filosa R; De Rosa M; La Gatta A
Carbohydr Polym; 2016 Nov; 153():275-283. PubMed ID: 27561497
[TBL] [Abstract][Full Text] [Related]
18. Colloidal nanosystems with mucoadhesive properties designed for ocular topical delivery.
Silva B; São Braz B; Delgado E; Gonçalves L
Int J Pharm; 2021 Sep; 606():120873. PubMed ID: 34246741
[TBL] [Abstract][Full Text] [Related]
19. Chitosan Nanoparticles as a Mucoadhesive Drug Delivery System for Ocular Administration.
Silva MM; Calado R; Marto J; Bettencourt A; Almeida AJ; Gonçalves LMD
Mar Drugs; 2017 Dec; 15(12):. PubMed ID: 29194378
[TBL] [Abstract][Full Text] [Related]
20. Autologous serum eye drops for dry eye.
Pan Q; Angelina A; Marrone M; Stark WJ; Akpek EK
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD009327. PubMed ID: 28245347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
